UNSPSC 51411606: Oxyfedrine

This classification denotes a vasodilating agent and beta-adrenergic agonist with the molecular formula C19H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DWL616XF1K, chemically known as 3-(((alphas,betar)-beta-hydroxy-alpha-methylphenethyl)amino)-3-methoxypropiophenone but generally known as oxyfedrine, which bears US NIH Compound Identifier 27454. European Medicines Agency schedules Oxyfedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09564MIG.

UNSPSC 51411606 Oxyfedrine is a Commodity code covering emergency pharmaceutical supplies and medications purchased by state and local health agencies, fire rescue departments, and pharmacy benefit programs. State and local governments buy advanced life support medications, generic pharmaceuticals, and over-the-counter products under this code to support emergency medical services, state employee health plans, and institutional pharmacy operations. The issuing bodies span city fire departments, state health and human services commissions, and multistate cooperative purchasing alliances administering consolidated procurement on behalf of member jurisdictions and their health facilities.

Activity under the code concentrates in Florida, Texas, and Minnesota based on recent solicitations. The City of Tampa's Purchasing Department solicited sealed bids (IFB No. 26P00188) for advanced life support medications including epinephrine, labetalol, adenosine, and diltiazem vials for Tampa Fire Rescue, with an estimated contract value of $40,000 and a response deadline of April 8, 2026; the procurement included a 5 percent bid discount for Small Local Business Enterprise participation. The Texas Health and Human Services Commission issued a Request for Information (RFI No. HHS0017013) on March 27, 2026, to assess vendor capacity for direct-to-manufacturer prescription programs serving state employees and group health plans outside traditional pharmacy benefit manager channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP (S1070000015802) with a March 26, 2026, response deadline to establish contracts for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) to participating state and local facilities in Minnesota and Oregon, with contract effectiveness set for July 1, 2026. All three solicitations impose cGMP and FDA compliance requirements, require comprehensive product documentation including NDC codes and safety data sheets, and mandate insurance minimums ranging from $2 million to $5 million.